Issuer Free Writing Prospectus filed pursuant to Rule 433

supplementing the Preliminary Prospectus Supplement dated May 13, 2010

Registration No. 333-166710

May 13, 2010

Omnicare, Inc.

Pricing Supplement

Pricing Supplement dated May 13, 2010 to Preliminary Prospectus Supplement dated May 13, 2010 of Omnicare, Inc. This Pricing Supplement is qualified in its entirety by reference to the Preliminary Prospectus Supplement. The information in this Pricing Supplement supplements the Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Financial information present in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by changes described herein. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the Preliminary Prospectus Supplement.

 

Issuer    Omnicare, Inc.
Aggregate Principal Amount    $400,000,000
Title of Security    7.750% Senior Subordinated Notes due 2020
Maturity    June 1, 2020
Coupon    7.750%
Public Offering Price    100.000% plus accrued interest, if any, from May 18, 2010
Yield to Maturity    7.750%
Spread to Treasury    +421 bps
Benchmark    UST 3.625% due February 15, 2020
Interest Payment Dates    June 1 and December 1 of each year, beginning on December 1, 2010
Gross Proceeds    $400,000,000
Underwriting Discount    2.000%
Net Proceeds to Issuer before Expenses    $392,000,000
Optional Redemption   
   On or after June 1, 2015 at the following redemption prices plus accrued and unpaid interest, if any:
     

Year

   Percentage      
  

2015

   103.875  
  

2016

   102.583  
  

2017

   101.292  
  

2018 and thereafter

   100.000  


Make-whole call:

   Prior to June 1, 2015 at 100% plus the excess of discounted present value at Treasury plus 50 basis points over outstanding principal amount, plus accrued and unpaid interest, if any.

Optional Redemption with Equity Proceeds:

   At any time prior to June 1, 2013, up to 35% may be redeemed at 107.750% plus accrued and unpaid interest, if any.
Change of Control    Upon certain change of control events, each holder may require the Issuer to repurchase at 101%, plus accrued and unpaid interest, if any
Use of Proceeds    Repurchase the Issuer’s 6.75% Senior Subordinated Notes due 2013, repay amounts outstanding under the Issuer’s senior credit facility and for general corporate purposes, which may include the repurchase of shares of Issuer’s common stock from time to time.
Trade Date    May 13, 2010
Settlement Date    May 18, 2010 (T+3)
Ratings*   

Moody’s: Ba2

S&P: BB

Denominations    $2,000 and integral multiples of $1,000
CUSIP/ISIN Numbers   

CUSIP: 681904 AM0

ISIN: US681904AM08

Form of Offering    SEC Registered (Registration No. 333-166710)
Joint Book-Running Managers   

J.P. Morgan Securities Inc.

Barclays Capital Inc.

Citigroup Global Markets Inc.

SunTrust Robinson Humphrey, Inc.

Co-Managers   

Daiwa Capital Markets America Inc.
Goldman, Sachs & Co.

The Huntington Investment Company

KeyBanc Capital Markets Inc.

Mitsubishi UFJ Securities (USA), Inc.

RBC Capital Markets Corporation

RBS Securities Inc.

U.S. Bancorp Investments, Inc.

Allocation   

Name

   Principal Amount of
Notes to be Purchased
    
   J.P. Morgan Securities Inc.    $ 130,000,000   
   Barclays Capital Inc.      70,000,000   
   Citigroup Global Markets Inc.      70,000,000   
   SunTrust Robinson Humphrey, Inc.      60,000,000   
   Daiwa Capital Markets America Inc.      3,000,000   

 

- 2 -


   Goldman, Sachs & Co    10,000,000   
   The Huntington Investment Company    8,000,000   
   KeyBanc Capital Markets Inc.    8,000,000   
   Mitsubishi UFJ Securities (USA), Inc.    11,000,000   
   RBC Capital Markets Corporation    8,000,000   
   RBS Securities Inc.    11,000,000   
   U.S. Bancorp Investments, Inc.    11,000,000   

 

* A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

The issuer has filed a registration statement (including a prospectus) with the United States Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling collect 1-212-834-4533.

 

- 3 -